Ananddas Diagnostic Laboratory Profile
Key Indicators
- Authorised Capital ₹ 3.60 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.60 Cr
as on 24-10-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -3.78%
(FY 2023)
- Profit 89.32%
(FY 2023)
- Ebitda 160.75%
(FY 2023)
- Net Worth -5.34%
(FY 2023)
- Total Assets -16.70%
(FY 2023)
About Ananddas Diagnostic Laboratory
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.60 Cr and a paid-up capital of Rs 3.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Athmanathan Ganesan, Jayaram Narayana, Sujay Ramaprasad, and One other member serve as directors at the Company.
- CIN/LLPIN
U85300KA2019PTC125626
- Company No.
125626
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2019
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Hassan, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ananddas Diagnostic Laboratory?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Athmanathan Ganesan  | Director | 23-Oct-2019 | Current |
| Jayaram Narayana | Director | 23-Oct-2019 | Current |
| Sujay Ramaprasad | Director | 23-Oct-2019 | Current |
| Devadasu Raju | Director | 26-Jun-2019 | Current |
Financial Performance of Ananddas Diagnostic Laboratory.
Ananddas Diagnostic Laboratory Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.78% decrease. The company also saw a substantial improvement in profitability, with a 89.32% increase in profit. The company's net worth dipped by a decrease of 5.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ananddas Diagnostic Laboratory?
In 2023, Ananddas Diagnostic Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neuberg Abha Laboratory Private LimitedActive 4 years 8 monthsAthmanathan Ganesan is a mutual person
Magnum Imaging & Diagnostics Private LimitedActive 11 years 3 monthsAthmanathan Ganesan is a mutual person
Anand Diagnostic Laboratory Private LimitedActive 3 years 20 daysAthmanathan Ganesan, Jayaram Narayana and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ananddas Diagnostic Laboratory?
Ananddas Diagnostic Laboratory has a workforce of 21 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ananddas Diagnostic Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ananddas Diagnostic Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
